Country Offices Contact Share
Library
  • Apr 10, 2017

2016 Progress Report

From the launch of M-TIBA to disbursing the 1000th loan and winning the FT/IFC Transformational Business Award, 2016 was an eventful year for PharmAccess. Find out more in our progress report!

In many ways, 2016 marked a transition for our organization. Although we’ve been developing and testing mobile phone-based health solutions since 2013, the past year is when it all started to come together. Not only did we launch the M-TIBA mobile health wallet in Kenya, but our mHealth labs in Tanzania, Ghana and Nigeria have also started to take shape. It was also the year in which we further developed our digital agenda. From 2017 onwards, this digital agenda will be the cornerstone to our approach.

Read more about these and other highlights in our 2016 Progress Report.

 

Suggested further reads

Disrupting Health Care: PPPs as a Model Adoption for Health System Strengthening in Nigeria
The health policy dialogue titled ‘Disrupting Health Care: PPPs as a Model Adoption for Health System Strengthening’ demonstrated how public-private partnerships (PPPs) could be used as a model to invest in healthcare infrastructure, and therefore enable governments to allocate scarce capital resources more effectively, improve health outcomes, and foster economic growth by reducing medical tourism. The aim of the policy dialogue was to have a wider discussion, gather a broader view of private sector engagement in healthcare and highlight ensuing benefits to the concerned entities.
May 17, 2019 publication
2017 Progress Report
2017 was an important year for PharmAccess in which we collaborated with some of the most innovative organizations and focused on strengthening our digital health agenda.
Aug 29, 2018 publication
NCD-RisC paper on global trends in risk factors for non-communicable diseases
The Non-Communicable Disease Risk Factor Collaboration (NCD-RisC) has collected and analysed data from over 2,545 population-based studies in almost 200 countries, on major risk factors for non-communicable diseases. The Amsterdam Institute for Global Health and Development (AIGHD) and PharmAccess contributed to this research by delivering data from their impact evaluations in Nigeria and Namibia.
Dec 04, 2017 publication